Learning Objectives to appreciate the importance of MRD...
MRD Assessment in Adult ALL…Why and How?
read more
Podcasts
Maximizing Patient Outcomes in Adult Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Learning Objectives Discuss strategies to give patients...
Maximizing Outcomes in Relapsed Multiple Myeloma / Maximiser les résultats dans le myélome multiple récidivant
Learning Objectives L'attrition des patients dans toutes...
The Critical Role of MRD Testing in Acute Lymphoblastic Leukemia
Learning objetives Discuss the benefits of MRD testing...
BEST OF LUNG CANCER SUMMIT 2020: SURGICAL UPDATE – IMPACT OF COVID-19 ON LUNG CANCER SURGERY
Learning objetives 1. Describe the current and future...
Moving towards personalized approaches in multiple myeloma
Learning objetives Discuss strategies for tailoring care...
Multiple Myeloma: Treatment at first relapse
Learning objectives Review updated clinical data on...
BEST OF ONCOLOGY EAST 2020: LUNCH SYMPOSIUM (MYLAN) – THE FUTURE OF BIOSIMILARS IN ONCOLOGY – IMPLEMENTING THE LESSONS FROM TODAY
Learning objetives 1. To discuss the pivotal oncology...
BEST OF ONCOLOGY EAST 2020: BREAST CANCER
Learning objetives 1. To discuss the pivotal oncology...
BEST OF ONCOLOGY EAST 2020: GI – COLORECTAL AND NON-COLORECTAL
Learning objetives To discuss the pivotal oncology trials...
BEST OF ONCOLOGY EAST 2020: MELANOMA
Learning objetives To discuss the pivotal oncology trials...
BEST OF ONCOLOGY EAST 2020: LUNG CANCER
Learning objetives To discuss the pivotal oncology trials...
Biomarker guided treatment in mCRC – who, how and when?
Learning objetives Review clinical data underlying...
How to communicate treatment choices in mCRC- a physician and patient perspective
Learning objetives The learning objectives are outlined in...
IMMUNO-ONCOLOGY SUMMIT 2020: GI – COLORECTAL AND NON-COLORECTAL
Learning objetives 1. Reviewing of basic principles of...
BEST OF LUNG CANCER SUMMIT 2020: THE FUTURE OF IMMUNO-ONCOLOGY IN SCLC IN CANADA & UPDATE ON NEW THERAPIES
Learning objetives 1. Describe the current and future...
IMMUNO-ONCOLOGY SUMMIT 2020: UNCOMMON ADVERSE-EVENTS
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: COMMON ADVERSE-EVENTS
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: BREAST CANCER
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: GU – PROSTATE AND NON-PROSTATE
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: LUNG CANCER
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: CELLULAR THERAPIES- Q&A
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: CELLULAR THERAPIES: PRODUCTION AND CHALLENGES
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: CELLULAR THERAPIES- CLINICAL OVERVIEW
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: HEAD AND NECK CANCERS
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: BIOMARKERS IN IMMUNO-ONCOLOGY
Learning objetives 1. Reviewing of basic principles of...
IMMUNO-ONCOLOGY SUMMIT 2020: DRUG DEVELOPMENT IN IMMUNO-ONCOLOGY
Learning objetives 1. Reviewing of basic principles of...
BEST OF LUNG CANCER SUMMIT 2020: SCREENING UPDATE
Learning objetives 1. Describe the current and future...
BEST OF LUNG CANCER SUMMIT 2020: IMMUNOTHERAPY DEBATE: WHAT IS THE BEST TREATMENT FOR PDL1-NEGATIVE PATIENTS WITH ADVANCED NSCLC? PART -1
Learning objetives 1. Describe the current and future...
BEST OF LUNG CANCER SUMMIT 2020: ADJUVANT THERAPY IN RESECTED NSCLC EGFRM+ – PITFALLS IN ADAURA
Learning objetives 1. Describe the current and future...
BEST OF LUNG CANCER SUMMIT 2020: ADJUVANT THERAPY IN RESECTED NSCLC EGFRM+ – PITFALLS IN ADAURA
BEST OF LUNG CANCER SUMMIT 2020: ADJUVANT THERAPY IN RESECTED NSCLC EGFRM+ – WHY WE ADORE ADAURA
Learning objetives 1. Describe the current and future...
BEST OF LUNG CANCER SUMMIT 2020: CURRENT STATE OF BIOMARKER TESTING
Learning objetives 1. Describe the current and future...
BEST OF LUNG CANCER SUMMIT 2020: IMMUNOTHERAPY DEBATE: WHAT IS THE BEST TREATMENT FOR PDL1-NEGATIVE PATIENTS WITH ADVANCED NSCLC? PART -2
Learning objetives 1. Describe the current and future...
IMPLEMENTATION OF BIOSIMILARS INTO CLINICAL PRACTICE
Learning objetives You Might Also Be Interested InYour...
How do I treat mCRC in Canada- translating the evidence to local clinical practice
Learning objetives Discuss the treatment of metastatic...